Evidence mapPaperPMID 41149608Full record

ReviewMarine drugs2025

Microbial Blue Bioprospecting: Exploring the Advances of Compounds Post-Discovery.

Cristiana Roberta Multisanti, Valeria Celi, Aurora Dibra, Angela Pintus, Rosario Calogero, Carmen Rizzo, Caterina Faggio

Abstract readReview
In one paragraph

Review in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cristiana Roberta MultisantiDepartment of Veterinary Sciences, University of Messina, 98168 Messina, Italy.ORCID 0000-0002-6283-2502
Valeria CeliDepartment of Chemical Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.
Aurora DibraDepartment of Biology and Chemistry, Faculty of Natural Sciences, University "Luigj Gurakuqi" of Shkodra, 4000 Shkodra, Albania.
Angela PintusNational Research Council of Italy (CNR), Institute for Organic Synthesis and Photoreactivity (ISOF), Via Piero Gobetti 101, 40129 Bologna, Italy.
Rosario CalogeroStazione Zoologica Anton Dohrn, Department of Ecosustainable Marine Biotechnology, Sicily Marine Centre, C. da Porticatello, 29-Villa Pace, 98167 Messina, Italy.
Carmen RizzoStazione Zoologica Anton Dohrn, Department of Ecosustainable Marine Biotechnology, Sicily Marine Centre, C. da Porticatello, 29-Villa Pace, 98167 Messina, Italy.ORCID 0000-0002-4340-3833
Caterina FaggioDepartment of Chemical Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.ORCID 0000-0002-0066-2421

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine biotechnology is an emerging field of research. There is scientific evidence of the strong potential of a multitude of marine microorganisms in biotechnology, with applications spanning the medical, pharmaceutical, cosmeceutical, nutraceutical and environmental recovery fields. However, despite the discovery of new natural compounds being of wide-ranging benefit, their practical application still remains difficult due to costs and lengthy validation processes. The strength of natural compounds is that, unlike synthetic or already-known compounds, they can have more specific functions and are generally environmentally friendly. This requires, however, that each newly discovered compound be assayed for its toxicity through tests on model cells and organisms. Research should therefore not stop with the simple discovery of new compounds but go beyond with the validation of their efficacy and safety, an issue that remains poorly addressed for products of marine bacterial origin. This review analyses current knowledge on natural compounds of marine bacterial origin, trying to focus on the necessary steps after their discovery, including the investigation of their non-toxicity to model organisms.

Indexed as

Aquatic OrganismsBacteriaBiological ProductsBioprospectingAnimalsBiotechnologyDrug DiscoveryHumansBiological Productsbioprospectingbiotechnologymarine bacteriamodel organismstoxicity

Identifiers

PMID41149608
PMCPMC12565130

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.